Phio Pharmaceuticals Corp. · NASDAQ:PHIO
Plott Ronald Todd bought 10,000 Phio Pharmaceuticals Corp. shares (Form 4)
Traded Sep 28 to Sep 29, 2026 · Filed Sep 30, 2026
From Sep 28 to Sep 29, 2026, Plott Ronald Todd (Director) bought 10,000 Phio Pharmaceuticals Corp. shares at an average US$1.04 for US$10,350, leaving 42,000 shares. Filed Sep 30, 2026 (Form 4).
- Bought
- 10,000 shares
- Price
- US$1.04 average (US$1.03 to US$1.04)
- Value
- US$10,350
- Holding after
- 42,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Common Stock, $.0001 par value | Buy | 5,000 | US$1.03 | 37,000 | Direct |
| Sep 29, 2026 | Common Stock, $.0001 par value | Buy | 5,000 | US$1.04 | 42,000 | Direct |
Source
Related
- Phio Pharmaceuticals Corp.
- Plott Ronald Todd
- Phio Pharmaceuticals Corp. shareholders
- Form 4 · Plott Ronald Todd · Sep 29, 2026
- Form 4 · Plott Ronald Todd · Aug 20, 2026
- Form 4 · Bitterman Robert J · Sep 29, 2026
- Form 4 · Carson Lisa Cabott · Sep 29, 2026
- Form 4 · Bradford Patricia A · Sep 25, 2026
- Form 4 · Bitterman Robert J · Sep 23, 2026
- Form 4 · Bradford Patricia A · Sep 16, 2026